<VariationArchive VariationID="6066" VariationName="NM_004260.4(RECQL4):c.1573del (p.Cys525fs)" VariationType="Deletion" Accession="VCV000006066" Version="39" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="14" DateLastUpdated="2024-07-15" DateCreated="2013-07-24" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21105" VariationID="6066">
      <GeneList>
        <Gene Symbol="RECQL4" FullName="RecQ like helicase 4" GeneID="9401" HGNC_ID="HGNC:9949" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144511288" stop="144517833" display_start="144511288" display_stop="144517833" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145736666" stop="145743209" display_start="145736666" display_stop="145743209" Strand="-" />
          </Location>
          <OMIM>603780</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004260.4(RECQL4):c.1573del (p.Cys525fs)</Name>
      <CanonicalSPDI>NC_000008.11:144514982:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="144514983" stop="144514983" display_start="144514983" display_stop="144514983" variantLength="1" positionVCF="144514982" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145740367" stop="145740367" display_start="145740367" display_stop="145740367" variantLength="1" positionVCF="145740366" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.145740367del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.145740367del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.144514983del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.144514983del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016430.2" sequenceAccession="NG_016430" sequenceVersion="2" change="g.7844del">
            <Expression>NG_016430.2:g.7844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033083.1" sequenceAccession="NG_033083" sequenceVersion="1" change="g.2019del">
            <Expression>NG_033083.1:g.2019del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004260.4" sequenceAccession="NM_004260" sequenceVersion="4" change="c.1573del" MANESelect="true">
            <Expression>NM_004260.4:c.1573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004251.4" sequenceAccession="NP_004251" sequenceVersion="4" change="p.Cys525fs">
            <Expression>NP_004251.4:p.Cys525fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_277" sequenceAccession="LRG_277">
            <Expression>LRG_277:g.7844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_277t1" sequenceAccession="LRG_277t1">
            <Expression>LRG_277t1:c.1573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_277p1" sequenceAccession="LRG_277p1" change="p.Cys525fs">
            <Expression>LRG_277p1:p.Cys525fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004260.3" sequenceAccession="NM_004260" sequenceVersion="3" change="c.1573delT">
            <Expression>NM_004260.3:c.1573delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA144327" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603780.0005" DB="OMIM" />
        <XRef Type="rs" ID="386833845" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10678659 Fig. 3B to determine the location of this allele on the current reference sequence. </Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00024" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00026" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00031" Source="1000 Genomes Project 30x" />
        <AlleleFrequency Value="0.00033" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00051" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND Rothmund-Thomson syndrome" Accession="RCV000006438" Version="12">
        <ClassifiedConditionList TraitSetID="1680">
          <ClassifiedCondition DB="MedGen" ID="C0032339">Rothmund-Thomson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND Rapadilino syndrome" Accession="RCV000049813" Version="4">
        <ClassifiedConditionList TraitSetID="1681">
          <ClassifiedCondition DB="MedGen" ID="C1849453">Rapadilino syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND Baller-Gerold syndrome" Accession="RCV000169785" Version="11">
        <ClassifiedConditionList TraitSetID="1682">
          <ClassifiedCondition DB="MedGen" ID="C0265308">Baller-Gerold syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-25" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)" Accession="RCV000761024" Version="4">
        <ClassifiedConditionList TraitSetID="46537">
          <ClassifiedCondition DB="MedGen" ID="C2698314">B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-01-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND High grade surface osteosarcoma" Accession="RCV000761053" Version="4">
        <ClassifiedConditionList TraitSetID="46545">
          <ClassifiedCondition DB="MedGen" ID="C1266165">High grade surface osteosarcoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-07-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND Rothmund-Thomson syndrome type 2" Accession="RCV000984856" Version="4">
        <ClassifiedConditionList TraitSetID="51243">
          <ClassifiedCondition DB="MedGen" ID="C5203410">Rothmund-Thomson syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND not provided" Accession="RCV001529529" Version="23">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-12-16" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND multiple conditions" Accession="RCV001582468" Version="4">
        <ClassifiedConditionList TraitSetID="52003">
          <ClassifiedCondition DB="MedGen" ID="C0265308">Baller-Gerold syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1849453">Rapadilino syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5203410">Rothmund-Thomson syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-03-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004260.4(RECQL4):c.1573del (p.Cys525fs) AND Inborn genetic diseases" Accession="RCV002512832" Version="3">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-25" NumberOfSubmissions="16" NumberOfSubmitters="14" DateCreated="2013-07-24" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10678659</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12734318</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12838562</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12952869</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15897384</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15964893</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18716613</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20113479</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29367366</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31604778</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31829210</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301383</ID>
          <ID Source="BookShelf">NBK1204</ID>
        </Citation>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="51243" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="43045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rothmund-Thomson syndrome type 2</ElementValue>
                <XRef ID="MONDO:0016369" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTS2</ElementValue>
                <XRef Type="MIM" ID="268400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; juvenile cataracts; and an increased risk for cancer, especially osteosarcoma. A variety of benign and malignant hematologic abnormalities have been reported in affected individuals. The rash of RTS typically develops between ages three and six months (occasionally as late as age two years) as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively known as poikiloderma) that persist throughout life. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities can include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</Attribute>
                <XRef ID="NBK1237" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17135" />
                <XRef ID="17135" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301415</ID>
                <ID Source="BookShelf">NBK1237</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="221016" DB="Orphanet" />
              <XRef ID="C5203410" DB="MedGen" />
              <XRef ID="MONDO:0016369" DB="MONDO" />
              <XRef Type="MIM" ID="268400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52003" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3578" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Radial and patellar aplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Radial and patellar hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Absent thumbs, dislocated joints, long face with narrow palpebral fissures, long slender nose, arched palate</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rapadilino syndrome</ElementValue>
                <XRef ID="Rapadilino+syndrome/6152" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009955" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4637" />
                <XRef ID="4637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="3021" DB="Orphanet" />
              <XRef ID="C1849453" DB="MedGen" />
              <XRef ID="MONDO:0009955" DB="MONDO" />
              <XRef Type="MIM" ID="266280" DB="OMIM" />
            </Trait>
            <Trait ID="43045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rothmund-Thomson syndrome type 2</ElementValue>
                <XRef ID="MONDO:0016369" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTS2</ElementValue>
                <XRef Type="MIM" ID="268400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; juvenile cataracts; and an increased risk for cancer, especially osteosarcoma. A variety of benign and malignant hematologic abnormalities have been reported in affected individuals. The rash of RTS typically develops between ages three and six months (occasionally as late as age two years) as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively known as poikiloderma) that persist throughout life. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities can include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</Attribute>
                <XRef ID="NBK1237" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17135" />
                <XRef ID="17135" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301415</ID>
                <ID Source="BookShelf">NBK1237</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="221016" DB="Orphanet" />
              <XRef ID="C5203410" DB="MedGen" />
              <XRef ID="MONDO:0016369" DB="MONDO" />
              <XRef Type="MIM" ID="268400" DB="OMIM" />
            </Trait>
            <Trait ID="582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis with radial defects</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Baller-Gerold syndrome</ElementValue>
                <XRef ID="Craniosynostosis+Radial+Aplasia+Syndrome/1995" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009039" DB="MONDO" />
                <XRef ID="77608001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis radial aplasia syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BGS</ElementValue>
                <XRef Type="MIM" ID="218600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Baller-Gerold syndrome (BGS) can be suspected at birth in an infant with craniosynostosis and upper limb abnormality. The coronal suture is most commonly affected; the metopic, lambdoid, and sagittal sutures may also be involved alone or in combination. Upper limb abnormality can include a combination of thumb hypo- or aplasia and radial hypo- or aplasia and may be asymmetric. Malformation or absence of carpal or metacarpal bones has also been described. Skin lesions may appear anytime within the first few years after birth, typically beginning with erythema of the face and extremities and evolving into poikiloderma. Slow growth is apparent in infancy with eventual height and length typically at 4 SD below the mean.</Attribute>
                <XRef ID="NBK1204" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1602" />
                <XRef ID="1602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301383</ID>
                <ID Source="BookShelf">NBK1204</ID>
              </Citation>
              <XRef ID="1225" DB="Orphanet" />
              <XRef ID="C0265308" DB="MedGen" />
              <XRef ID="MONDO:0009039" DB="MONDO" />
              <XRef Type="MIM" ID="218600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="46537" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41522" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)</ElementValue>
                <XRef ID="450952005" DB="SNOMED CT" />
              </Name>
              <XRef ID="C2698314" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="46545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41529" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">High grade surface osteosarcoma</ElementValue>
                <XRef ID="MONDO:0006246" DB="MONDO" />
              </Name>
              <XRef ID="C1266165" DB="MedGen" />
              <XRef ID="MONDO:0006246" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1681" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3578" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Radial and patellar aplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Radial and patellar hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Absent thumbs, dislocated joints, long face with narrow palpebral fissures, long slender nose, arched palate</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rapadilino syndrome</ElementValue>
                <XRef ID="Rapadilino+syndrome/6152" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009955" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4637" />
                <XRef ID="4637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="3021" DB="Orphanet" />
              <XRef ID="C1849453" DB="MedGen" />
              <XRef ID="MONDO:0009955" DB="MONDO" />
              <XRef Type="MIM" ID="266280" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1682" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis with radial defects</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Baller-Gerold syndrome</ElementValue>
                <XRef ID="Craniosynostosis+Radial+Aplasia+Syndrome/1995" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009039" DB="MONDO" />
                <XRef ID="77608001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Craniosynostosis radial aplasia syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BGS</ElementValue>
                <XRef Type="MIM" ID="218600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Baller-Gerold syndrome (BGS) can be suspected at birth in an infant with craniosynostosis and upper limb abnormality. The coronal suture is most commonly affected; the metopic, lambdoid, and sagittal sutures may also be involved alone or in combination. Upper limb abnormality can include a combination of thumb hypo- or aplasia and radial hypo- or aplasia and may be asymmetric. Malformation or absence of carpal or metacarpal bones has also been described. Skin lesions may appear anytime within the first few years after birth, typically beginning with erythema of the face and extremities and evolving into poikiloderma. Slow growth is apparent in infancy with eventual height and length typically at 4 SD below the mean.</Attribute>
                <XRef ID="NBK1204" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RECQL4-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1602" />
                <XRef ID="1602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301383</ID>
                <ID Source="BookShelf">NBK1204</ID>
              </Citation>
              <XRef ID="1225" DB="Orphanet" />
              <XRef ID="C0265308" DB="MedGen" />
              <XRef ID="MONDO:0009039" DB="MONDO" />
              <XRef Type="MIM" ID="218600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1680" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4358" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Poikiloderma Congenitale</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Poikiloderma of Rothmund-Thomson</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rothmund-Thomson syndrome</ElementValue>
                <XRef ID="Rothmund+Thomson+syndrome/6363" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010002" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS268400" DB="OMIM" />
                <XRef ID="69093006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4392" />
                <XRef ID="4392" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; juvenile cataracts; and an increased risk for cancer, especially osteosarcoma. A variety of benign and malignant hematologic abnormalities have been reported in affected individuals. The rash of RTS typically develops between ages three and six months (occasionally as late as age two years) as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, telangiectasias, and punctate atrophy (collectively known as poikiloderma) that persist throughout life. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities can include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.</Attribute>
                <XRef ID="NBK1237" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301415</ID>
                <ID Source="BookShelf">NBK1237</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="2909" DB="Orphanet" />
              <XRef ID="C0032339" DB="MedGen" />
              <XRef ID="MONDO:0010002" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS268400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1153192" SubmissionDate="2017-07-05" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_004260.3(RECQL4):c.1573del|Rothmund-Thomson syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000596738" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Rothmund-Thomson syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1742404" SubmissionDate="2018-12-04" DateLastUpdated="2019-03-19" DateCreated="2019-03-19">
        <ClinVarSubmissionID localKey="NM_004260.3:c.1573delT|MedGen:C2698314" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000890939" DateUpdated="2019-03-19" DateCreated="2019-03-19" Type="SCV" Version="1" SubmitterName="St. Jude Molecular Pathology, St. Jude Children's Research Hospital" OrgID="506672" OrganizationCategory="laboratory" OrgAbbreviation="SJCRH-MP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C2698314" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4876888</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1742433" SubmissionDate="2018-12-04" DateLastUpdated="2019-03-19" DateCreated="2019-03-19">
        <ClinVarSubmissionID localKey="NM_004260.3:c.1573delT|MedGen:C1266165" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000890968" DateUpdated="2019-03-19" DateCreated="2019-03-19" Type="SCV" Version="1" SubmitterName="St. Jude Molecular Pathology, St. Jude Children's Research Hospital" OrgID="506672" OrganizationCategory="laboratory" OrgAbbreviation="SJCRH-MP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">High Grade Surface Osteosarcoma</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1266165" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4876888</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="26621" SubmissionDate="2021-06-11" DateLastUpdated="2021-06-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603780.0005_ROTHMUND-THOMSON SYNDROME, TYPE 2" title="RECQL4, 1-BP DEL, 1573T_ROTHMUND-THOMSON SYNDROME, TYPE 2" />
        <ClinVarAccession Accession="SCV000026621" DateUpdated="2021-06-15" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Rothmund-Thomson Syndrome, Type 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Lindor et al. (2000) identified a kindred in which 2 brothers with Rothmund-Thomson syndrome (RTS2; 268400) developed osteosarcomas. They were found to be compound heterozygous for mutations in the RECQL4 gene: a 1-bp deletion in exon 9 (c.1573delT, referred to as 'mut -5), resulting in a frameshift and premature termination codon , and a G-to-A transition at the 3-prime splice site in the intron-exon boundary of exon 8, resulting presumably in anomalous mRNA with a 93-bp deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">10678659</ID>
              </Citation>
              <XRef DB="OMIM" ID="268400" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Caucasian patient with sporadic RTS, Beghini et al. (2003) identified compound heterozygosity for 2 mutations of the RECQL4 gene: the c.1573delT on one allele and a G-to-C transversion at the 3-prime splice site of exon 13 (603780.0008) on the second allele. The patient had typical congenital poikiloderma and had bone defects in the form of aplasia of both thumbs and agenesis of both patellas. There was sensorineural deafness but no cataracts. (In the abstract of the article by Beghini et al. (2003), the 1573delT mutation is referred to as c.1473delT.)</Attribute>
              <Citation>
                <ID Source="PubMed">12838562</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a male patient with RTS and osteosarcoma and an unrelated female RTS patient without osteosarcoma, Wang et al. (2003) identified compound heterozygosity for a 1-bp deletion (g.2886delT) in exon 9 of the RECQL4 gene, resulting in a frameshift predicted to cause premature termination of the protein, and the Q757X mutation (603780.0002). An additional 4 RTS patients from 3 families, including 2 sibs with osteosarcoma, were compound heterozygous for g.2886delT and another mutation in RECQL4.</Attribute>
              <Citation>
                <ID Source="PubMed">12734318</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Baller-Gerold Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (g.2886delT) in the RECQL4 gene that was found in compound heterozygous state in a patient with Baller-Gerold syndrome (BGS; 218600) by Van Maldergem et al. (2006), see 603780.0012.</Attribute>
              <Citation>
                <ID Source="PubMed">15964893</ID>
              </Citation>
              <XRef DB="OMIM" ID="218600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <Name>RECQL4, 1-BP DEL, 1573T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1573T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603780.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ROTHMUND-THOMSON SYNDROME, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="400279" SubmissionDate="2021-06-11" DateLastUpdated="2021-06-15" DateCreated="2015-04-18">
        <ClinVarSubmissionID localKey="603780.0005_BALLER-GEROLD SYNDROME" title="RECQL4, 1-BP DEL, 1573T_BALLER-GEROLD SYNDROME" />
        <ClinVarAccession Accession="SCV000221750" DateUpdated="2021-06-15" DateCreated="2015-04-18" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Rothmund-Thomson Syndrome, Type 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Lindor et al. (2000) identified a kindred in which 2 brothers with Rothmund-Thomson syndrome (RTS2; 268400) developed osteosarcomas. They were found to be compound heterozygous for mutations in the RECQL4 gene: a 1-bp deletion in exon 9 (c.1573delT, referred to as 'mut -5), resulting in a frameshift and premature termination codon , and a G-to-A transition at the 3-prime splice site in the intron-exon boundary of exon 8, resulting presumably in anomalous mRNA with a 93-bp deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">10678659</ID>
              </Citation>
              <XRef DB="OMIM" ID="268400" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Caucasian patient with sporadic RTS, Beghini et al. (2003) identified compound heterozygosity for 2 mutations of the RECQL4 gene: the c.1573delT on one allele and a G-to-C transversion at the 3-prime splice site of exon 13 (603780.0008) on the second allele. The patient had typical congenital poikiloderma and had bone defects in the form of aplasia of both thumbs and agenesis of both patellas. There was sensorineural deafness but no cataracts. (In the abstract of the article by Beghini et al. (2003), the 1573delT mutation is referred to as c.1473delT.)</Attribute>
              <Citation>
                <ID Source="PubMed">12838562</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a male patient with RTS and osteosarcoma and an unrelated female RTS patient without osteosarcoma, Wang et al. (2003) identified compound heterozygosity for a 1-bp deletion (g.2886delT) in exon 9 of the RECQL4 gene, resulting in a frameshift predicted to cause premature termination of the protein, and the Q757X mutation (603780.0002). An additional 4 RTS patients from 3 families, including 2 sibs with osteosarcoma, were compound heterozygous for g.2886delT and another mutation in RECQL4.</Attribute>
              <Citation>
                <ID Source="PubMed">12734318</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Baller-Gerold Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (g.2886delT) in the RECQL4 gene that was found in compound heterozygous state in a patient with Baller-Gerold syndrome (BGS; 218600) by Van Maldergem et al. (2006), see 603780.0012.</Attribute>
              <Citation>
                <ID Source="PubMed">15964893</ID>
              </Citation>
              <XRef DB="OMIM" ID="218600" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <Name>RECQL4, 1-BP DEL, 1573T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1573T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603780.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">BALLER-GEROLD SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3562561" SubmissionDate="2021-09-01" DateLastUpdated="2021-09-08" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="NM_004260.3:c.1573delT|MedGen:C0265308;C1849453;C5203410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001821456" DateUpdated="2021-09-08" DateCreated="2021-09-08" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18716613</ID>
          </Citation>
          <Comment>Variant summary: RECQL4 c.1573delT (p.Cys525AlafsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by other laboratories (ClinVar). The variant allele was found at a frequency of 0.00024 in 245124 control chromosomes (gnomAD). c.1573delT has been reported in the literature in multiple individuals affected with RECQL4-Related Disorders (e.g. Siitonen_2009). These data indicate that the variant is very likely to be associated with disease. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265308" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1849453" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C5203410" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10303367</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3431112" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.8_145740366_145740367_CA_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001743119" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="C" referenceAllele="CA" start="145740366" stop="145740367" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3833661" SubmissionDate="2021-09-30" DateLastUpdated="2021-10-02" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey=":Chr.8_145740366_145740367_CA_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001956622" DateUpdated="2021-10-02" DateCreated="2021-10-02" Type="SCV" Version="1" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="C" referenceAllele="CA" start="145740366" stop="145740367" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10449206</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3852594" SubmissionDate="2021-09-21" DateLastUpdated="2021-10-07" DateCreated="2021-10-07">
        <ClinVarSubmissionID localKey=":Chr.8_145740366_145740367_CA_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001966161" DateUpdated="2021-10-07" DateCreated="2021-10-07" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="C" referenceAllele="CA" start="145740366" stop="145740367" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10405229</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5021678" SubmissionDate="2022-08-25" DateLastUpdated="2022-10-01" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="NM_004260.3:c.1573del|OMIM:218600" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002567920" DateUpdated="2022-10-01" DateCreated="2022-08-29" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1204</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265308" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11972032</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5446302" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_004260.4:c.1573del|OMIM:218600;266280;268400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002798881" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.4:c.1573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266280" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8196148" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="178183|MedGen:C0265308" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004411748" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12734318</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12952869</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10678659</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12838562</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15897384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15964893</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18716613</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20113479</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29367366</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31829210</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys525Alafs*33) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs386833845, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with RAPADILINO, Baller-Gerold syndrome, and RothmundThomson syndrome (PMID: 10678659, 12838562, 15897384, 15964893, 18716613, 20113479, 29367366, 31829210). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as g.2886delT. ClinVar contains an entry for this variant (Variation ID: 6066). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.145740367del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265308" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6371998" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a015983|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003682420" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15964893</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18716613</ID>
          </Citation>
          <Comment>The c.1573delT (p.C525Afs*33) alteration, located in exon 9 (coding exon 9) of the RECQL4 gene, consists of a deletion of one nucleotide at position 1573, causing a translational frameshift with a predicted alternate stop codon after 33 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant has been reported in the homozygous and compound heterozygous states in individuals with RECQL4-related disorders with and without malignancies (Van Maldergem, 2006; Siitonen, 2009). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4980744" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="116721|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002545656" DateUpdated="2024-07-15" DateCreated="2022-07-09" Type="SCV" Version="13" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>RECQL4: PVS1, PS4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="6" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="8" alternateAllele="C" referenceAllele="CA" start="145740366" stop="145740367" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131611" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS562" />
        <ClinVarAccession Accession="SCV000082222" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment>Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Rapadilino syndrome</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="266280" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4062340" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2022-02-04">
        <ClinVarSubmissionID localKey="GDXSV:269857" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002072823" DateUpdated="2023-05-06" DateCreated="2022-02-04" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31829210, 29367366, 28423363, 12734318, 12838562, 18716613, 15964893, 30947698, 31604778, 29625052, 32081490, 31980526, 31589614, 10678659, 34308104)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RECQL4" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:52872</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004260.3:c.1573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_182_20230503054203</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_86_20220202054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3852594" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26621" TraitType="Disease" MappingType="Name" MappingValue="ROTHMUND-THOMSON SYNDROME, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C5203410" Name="Rothmund-Thomson syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446302" TraitType="Disease" MappingType="XRef" MappingValue="268400" MappingRef="OMIM">
        <MedGen CUI="C5203410" Name="Rothmund-Thomson syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3562561" TraitType="Disease" MappingType="XRef" MappingValue="C1849453" MappingRef="MedGen">
        <MedGen CUI="C1849453" Name="Rapadilino syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4980744" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1153192" TraitType="Disease" MappingType="Name" MappingValue="Rothmund-Thomson syndrome" MappingRef="Preferred">
        <MedGen CUI="C0032339" Name="Rothmund-Thomson syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="400279" TraitType="Disease" MappingType="Name" MappingValue="BALLER-GEROLD SYNDROME" MappingRef="Alternate">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8196148" TraitType="Disease" MappingType="XRef" MappingValue="C0265308" MappingRef="MedGen">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3562561" TraitType="Disease" MappingType="XRef" MappingValue="C5203410" MappingRef="MedGen">
        <MedGen CUI="C5203410" Name="Rothmund-Thomson syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131611" TraitType="Disease" MappingType="Name" MappingValue="Rapadilino syndrome" MappingRef="Preferred">
        <MedGen CUI="C1849453" Name="Rapadilino syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3562561" TraitType="Disease" MappingType="XRef" MappingValue="C0265308" MappingRef="MedGen">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3431112" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446302" TraitType="Disease" MappingType="XRef" MappingValue="218600" MappingRef="OMIM">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6371998" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4062340" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1742433" TraitType="Disease" MappingType="Name" MappingValue="High Grade Surface Osteosarcoma" MappingRef="Preferred">
        <MedGen CUI="C1266165" Name="High grade surface osteosarcoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3833661" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446302" TraitType="Disease" MappingType="XRef" MappingValue="266280" MappingRef="OMIM">
        <MedGen CUI="C1849453" Name="Rapadilino syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021678" TraitType="Disease" MappingType="XRef" MappingValue="C0265308" MappingRef="MedGen">
        <MedGen CUI="C0265308" Name="Baller-Gerold syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1742404" TraitType="Disease" MappingType="Name" MappingValue="B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1" MappingRef="Preferred">
        <MedGen CUI="C2698314" Name="B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="3" DateDeleted="2015-04-16">SCV000026629</Accession>
      </SCV>
      <SCV>
        <Accession Version="3" DateDeleted="2015-04-16">SCV000026630</Accession>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002020783</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

